MEDICINES CO's ticker is and the CUSIP is 584688AG0. A total of 46 filers reported holding MEDICINES CO in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $10,409,000 | +7.2% | 12,300,000 | -3.9% | 0.57% | -12.1% |
| Q4 2018 | $9,711,000 | -47.5% | 12,800,000 | -36.9% | 0.64% | -19.0% |
| Q3 2018 | $18,512,000 | -51.2% | 20,300,000 | -46.3% | 0.80% | -39.8% |
| Q2 2018 | $37,946,000 | +0.9% | 37,800,000 | -3.1% | 1.32% | -11.5% |
| Q1 2018 | $37,598,000 | +25.7% | 39,000,000 | +20.0% | 1.49% | +17.5% |
| Q4 2017 | $29,921,000 | +137.5% | 32,500,000 | +170.8% | 1.27% | +157.8% |
| Q3 2017 | $12,599,000 | +248.2% | 12,000,000 | +247.8% | 0.49% | +177.0% |
| Q2 2017 | $3,618,000 | – | 3,450,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Man Investments (CH) AG | 3,000,000 | $2,762,000 | 2.59% |
| PT ASSET MANAGEMENT, LLC | 3,750,000 | $3,448,000 | 1.87% |
| ARISTEIA CAPITAL, L.L.C. | 32,500,000 | $29,921,000 | 1.27% |
| ZAZOVE ASSOCIATES LLC | 22,710,000 | $20,905,000 | 1.23% |
| PFM Health Sciences, LP | 34,471,000 | $31,692,000 | 0.75% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 24,215,000 | $22,262,000 | 0.63% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 36,000,000 | $33,075,000,000 | 0.59% |
| Partner Investment Management, L.P. | 479,000 | $440,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 4,808,000 | $4,398,000 | 0.37% |
| WOLVERINE ASSET MANAGEMENT LLC | 32,315,000 | $29,732,000 | 0.30% |